Back
Marker Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
36
MRKR
Marker Therapeutics
Last Price:
3.69
Seasonality Move:
8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is moderately bearish and MRKR is experiencing slight selling pressure.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.89 | Sell |
| 20-day SMA: | 3.92 | Sell |
| 50-day SMA: | 3.26 | Buy |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 3.96 | Sell |
| 20-day EMA: | 3.8 | Sell |
| 50-day EMA: | 3.6 | Buy |
| 200-day EMA: | 3.87 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 51.62 | Buy |
| Chaikin Money Flow: | -3493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.06 - 4.28) | Buy |
| Bollinger Bands (100): | (2.96 - 4.82) | Sell |
Marker Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 3.79 while MRKR 8-day simple moving average is 3.89, which is a Sell signal.
- The stock price of MRKR is 3.79 while Marker Therapeutics 20-day SMA is 3.92, which makes it a Sell.
- Marker Therapeutics 50-day simple moving average is 3.26 while MRKR share price is 3.79, making it a Buy technically.
- MRKR stock price is 3.79 and Marker Therapeutics 200-day simple moving average is 4.05, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
36
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a Sell
The current Marker Therapeutics [MRKR] share price is $3.79. The Score for MRKR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
33.82M
Price in USD:
3.79
Share Volume:
26.22K
Marker Therapeutics 52-Week Range
52-Week High:
6.16
52-Week Low:
2.44
Sell
36
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?
The Marker Therapeutics stock price is 3.79 USD today. -
Will MRKR stock go up or go down?
Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Marker Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 3.79 while MRKR 8-day exponential moving average is 3.96, which is a Sell signal.
- The stock price of MRKR is 3.79 while Marker Therapeutics 20-day EMA is 3.80, which makes it a Sell.
- Marker Therapeutics 50-day exponential moving average is 3.60 while MRKR share price is 3.79, making it a Buy technically.
- MRKR stock price is 3.79 and Marker Therapeutics 200-day simple moving average is 3.87, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
- MRKR Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Marker Therapeutics is a Buy
- Marker Therapeutics Relative Strength Index (RSI) is 51.62, which suggest Marker Therapeutics is overbought
- The Bollinger Bands (25) for Marker Therapeutics is (3.06 - 4.28), which suggest Marker Therapeutics is a Sell
- The Bollinger Bands (100) for Marker Therapeutics is (2.96 - 4.82), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.